+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Studies on the translocation inhibitor of tritium labeled dexamethasone receptor complex

Endocrinologia Japonica 26(4): 431-438
Studies on the translocation inhibitor of tritium labeled dexamethasone receptor complex
Recent reports on the binding of glucocorticoid-receptor complexes to rat liver nuclei suggested the presence of components which inhibited the binding. The inhibitory component(s) of the receptor translocation was observed not only in the cytosol of the liver but also in cytosols of the kidney, the spleen and the thymus. The cytoplasmic levels of the inhibitor in these tissues were not modified by the administration of dexamethasone (DEX). The liver inhibitor was macromolecular and clearly separated from the DEX-receptor complex on DEAE-cellulose chromatography. The mechanism of the inhibition seemed to be an interaction between the inhibitor and the steroid-receptor complex. In addition, the inhibition seemed to be less specific for the bindings of different steroid-receptor complexes to nuclei. The bindings of hepatic 3H-DEX-receptor complex by nuclei derived from livers of adrenalectomized and DEX-treated rats, in the presence or absence of the translocation inhibitor, were similar.

(PDF 0-2 workdays service: $29.90)

Accession: 006522623

Related references

Cardiac receptors for gluco corticoids in the rat factors involved in tritium labeled dexamethasone binding and nuclear translocation of tritium labeled dexamethasone receptor complexes in heart and liver. Biochimica et Biophysica Acta 586(1): 70-86, 1979

Studies on the translocation inhibitor of 3H-dexamethasone-receptor complex. Endocrinologia Japonica 26(4): 431-437, 1979

Interaction of tritium labeled dexamethasone receptor complex with nuclei inhibition by ethidium bromide. Endocrinologia Japonica 27(1): 101-106, 1980

Nuclear binding of steroid hormone receptor complex characteristics of binding of nuclei from fetal rat liver to tritium labeled dexamethasone liver cytoplasmic receptor complex. Endocrinologia Japonica 26(6): 679-686, 1979

In vitro incorporation of tritium labeled proline tritium labeled glucosamine and sulfur 35 labeled sulfate into the outflow region of the rabbit eye effect of dexamethasone. Investigative Ophthalmology & Visual Science 22(3 SUPPL): 92, 1982

2 distinct alpha 1 adrenergic receptor sites in rat liver differential binding of tritium labeled levo norepinephrine tritium labeled prazosin and tritium labeled di hydro ergocryptine effects of guanine nucleotides and proteolysis implications for a 2 site model of alpha receptor regulation. Biochemical Pharmacology 30(12): 1665-1676, 1981

3 classes of dopamine receptor d 2 d 3 d 4 identified by binding studies with tritium labeled apo morphine and tritium labeled domperidone. Naunyn-Schmiedeberg's Archives of Pharmacology 315(2): 89-102, 1980

Sedimentation analysis of the tritium labeled dexamethasone receptor complex released from the nuclei of hormone sensitive and hormone insensitive hepatoma cells. Journal of the Faculty of Science University of Tokyo Section IV Zoology 15(1): 63-70, 1981

Computer assisted analysis of receptor binding studies of tritium labeled naloxone and tritium labeled 2 d alanine 5 d leucine enkephalin a reinterpretation of the sodium effect. Life Sciences 33(SUPPL 1): 163-166, 1983

Autoradiographic studies of tritium labeled glycine tritium labeled gamma aminobutyric acid and tritium labeled muscimol uptake in the mudpuppy necturus maculosus retina. Experimental Eye Research 39(1): 69-82, 1984